1
|
Calado R, Relvas M, Morgado F, Cardoso JC, Tellechea O. Specific cutaneous infiltrates in patients with haematological neoplasms: a retrospective study with 49 patients. Australas J Dermatol 2021; 62:e228-e235. [PMID: 33403659 DOI: 10.1111/ajd.13533] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2020] [Revised: 11/15/2020] [Accepted: 11/21/2020] [Indexed: 11/29/2022]
Abstract
BACKGROUND Haematological neoplasms account for around 9% of all cancers, and they are recognised as an important cause of skin infiltration. However, studies analysing cutaneous metastasis of haematological neoplasms are scarce. We describe the clinical spectrum and outcomes of specific cutaneous manifestations of leukaemias, lymphomas, multiple myeloma (MM), and blastic plasmacytoid dendritic cell neoplasm (BPDN) and make a review of the literature. METHODS Data from 49 patients diagnosed with secondary cutaneous infiltration of systemic haematological neoplasms over the last 10 years in a tertiary dermatology centre were retrospectively collected, and clinical-evolutive features were analysed. RESULTS Most cases were lymphoma (44.9%, n = 22), followed by leukaemia cutis (38.8%, n = 19), secondary plasmacytoma (10.2%, n = 5) and BPDN (6.1%, n = 3). Nodules were the predominant type of lesion, and most patients presented with multiple (≥3) lesions. In 51% (n = 25) of cases, cutaneous infiltration was detected before the diagnosis of the underlying malignancy. The patients in diverse nosological groups did not differ in terms of survival (P = 0.052). CONCLUSIONS We recognise the clinical heterogeneity of specific cutaneous infiltrates. The high proportion of cases in which skin involvement was key to the diagnosis of systemic malignancy emphasises the role of the dermatologist in recognising and correctly managing these patients.
Collapse
Affiliation(s)
- Rebeca Calado
- Department of Dermatology, Coimbra Hospital and University Centre, Coimbra, Portugal
| | - Maria Relvas
- Department of Dermatology, Coimbra Hospital and University Centre, Coimbra, Portugal
| | - Francisca Morgado
- Department of Dermatology, Coimbra Hospital and University Centre, Coimbra, Portugal
| | - José Carlos Cardoso
- Department of Dermatology, Coimbra Hospital and University Centre, Coimbra, Portugal
| | - Oscar Tellechea
- Department of Dermatology, Coimbra Hospital and University Centre, Coimbra, Portugal
| |
Collapse
|
2
|
Zhao H, Huang WH, Huang JY, Lu SY, Yang YH, Ma ZG. Henoch-Schönlein purpura nephritis associated with monoclonal gammopathy of renal significance: a case report. ACTA ACUST UNITED AC 2019; 52:e8222. [PMID: 31291381 PMCID: PMC6694773 DOI: 10.1590/1414-431x20198222] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2018] [Accepted: 05/07/2019] [Indexed: 02/06/2023]
Abstract
Monoclonal gammopathy of renal significance (MGRS) can present with different morphologic features and lead to kidney failure. The Henoch-Schönlein purpura nephritis (HSPN) that cannot be relieved by treatment with glucocorticoid and immunosuppressive agents suggests the presence of monoclonal gammopathy in adult patients. The present study reports on a single case of HSPN associated with IgA-κMGRS. The patient who suffered from recurrent skin purpura for 6 months and nephrotic syndrome for 2 months was admitted to our hospital. Bone marrow biopsy showed monoclonal gammopathy of undetermined significance. Kidney biopsy indicated a Henoch-Schönlein purpura nephritis (HSPN, ISKDC classified as type III) with positive staining with κ-light chain in the glomeruli and renal tubular epithelial cells. Furthermore, skin biopsy showed leukocytoclastic vasculitis and negative staining for Congo red and light chain. Given both the renal and cutaneous involvement, the patient was considered to have HSPN associated with IgA-κMGRS. The patient experienced an exacerbation in his purpura-like lesions and clinical status after treatment with glucocorticoid and immunosuppressive agents. Consequently, the patient was put on a regimen that included dexamethasone (20 mg on the 1st, 4th, 8th, and 11th days of each month, iv) and bortezomib (2.4 mg on the 1st, 4th, 8th, and 11th days of each month, iv). Eight weeks after treatment, he had complete resolution of his cutaneous purpura and his biochemical parameters improved. The latent presence of MGRS in cases of HSPN should be considered in adult patients. Increased cognizance and correct treatment options could improve patient outcomes.
Collapse
Affiliation(s)
- Hui Zhao
- Department of Nephrology, Gansu Provincial Hospital, Lanzhou, Gansu, China
| | - Wen-Hui Huang
- Department of Nephrology, Gansu Provincial Hospital, Lanzhou, Gansu, China
| | - Jun-Yue Huang
- Department of Nephrology, Gansu Provincial Hospital, Lanzhou, Gansu, China
| | - Shou-Yan Lu
- Department of Nephrology, Gansu Provincial Hospital, Lanzhou, Gansu, China
| | - Ya-Hong Yang
- Department of Nephrology, Gansu Provincial Hospital, Lanzhou, Gansu, China
| | - Zhi-Gang Ma
- Department of Nephrology, Gansu Provincial Hospital, Lanzhou, Gansu, China
| |
Collapse
|
3
|
Woo YR, Kim JS, Lim JH, Hwang S, Kim M, Bae JM, Park YM, Min CK, Kim DW, Park HJ. Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: A case series from Korea. J Am Acad Dermatol 2018; 78:471-478.e4. [DOI: 10.1016/j.jaad.2017.08.054] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2017] [Revised: 08/25/2017] [Accepted: 08/28/2017] [Indexed: 12/11/2022]
|
4
|
Dika E, Ravaioli GM, Tacchetti P, Zamagni E, Fanti PA, Ribero S, Misciali C, Patrizi A. Dermoscopy of cutaneous involvement by multiple myeloma. J Am Acad Dermatol 2017; 76:S71-S72. [DOI: 10.1016/j.jaad.2016.08.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2016] [Revised: 07/21/2016] [Accepted: 08/01/2016] [Indexed: 11/30/2022]
|
5
|
Abstract
This article will focus on the cutaneous lymphoproliferative disorders associated with EBV, with an emphasis on the upcoming changes in the revised 4th Edition of the WHO classification of tumors of the hematopoietic system, many of which deal with cutaneous disorders derived from NK-cells or T-cells. Extranodal NK/T-cell lymphoma usually presents in the upper aerodigestive tract, but can involve the skin secondarily. EBV-associated T- and NK-cell lymphoproliferative disorders (LPD) in the pediatric age group include the systemic diseases, chronic active EBV infection (CAEBV) and systemic EBV+ T-cell lymphoma of childhood. Hydroa vacciniforme (HV)-like LPD is a primarily cutaneous form of CAEBV and encompasses the lesions previously referred to as HV and HV-like lymphoma (HVLL). All the T/NK-cell-EBV-associated diseases occur with higher frequency in Asians, and indigenous populations from Central and South America and Mexico. Among the B-cell EBV-associated LPD two major changes have been introduced in the WHO. The previously designated EBV-positive diffuse large B-cell lymphoma (EBV-DLBCL) of the elderly, has been changed to EBV-DLBCL with 'not otherwise specified' as a modifier (NOS). A new addition to the WHO system is the more recently identified EBV+ mucocutaneous ulcer, which involves skin and mucosal-associated sites.
Collapse
Affiliation(s)
- Alejandro A Gru
- Pathology & Dermatology, Hematopathology and Dermatopathology Sections, University of Virginia, Charlottesville, VA, USA.
| | - Elaine S Jaffe
- Hematopathology, National Cancer Institute (NCI), Bethesda, MD, USA
| |
Collapse
|
6
|
Jurczyszyn A, Olszewska-Szopa M, Hungria V, Crusoe E, Pika T, Delforge M, Leleu X, Rasche L, Nooka AK, Druzd-Sitek A, Walewski J, Davila J, Caers J, Maisnar V, Gertz M, Gentile M, Fantl D, Mele G, Vesole DH, Yee AJ, Shustik C, Lentzsch S, Zweegman S, Gozzetti A, Skotnicki AB, Castillo JJ. Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients. Leuk Lymphoma 2016; 57:2071-6. [PMID: 26726867 DOI: 10.3109/10428194.2015.1128542] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Skin infiltration in multiple myeloma (skin MM) is a rare clinical problem. Only a few cases of skin involvement have been reported, primarily in single case reports. We analyzed and present the clinical outcomes, immunohistochemistry and cytogenetic features, and relevant laboratory data on 53 biopsy-proven skin MM cases. The median time from MM diagnosis to skin involvement was 2 years. There appears to be an overrepresentation of immunoglobulin class A (IgA) and light chain disease in skin MM. We found no correlation between CD56 negative MM and skin infiltration. We found that skin MM patients presented in all MM stages (i.e. ISS stages I to III), and there was no preferential cytogenetic abnormality. Patients with skin MM carry a very poor prognosis with a median overall survival (OS) of 8.5 months as time from skin involvement. Moreover, patients with IgA disease and plasmablastic morphology appear to have a worse OS.
Collapse
Affiliation(s)
| | | | | | - Edvan Crusoe
- c Santa Casa Medical School , Sao Paulo , Brazil
| | - Tomas Pika
- d University Hospital Olomouc , Olomouc , Czech Republic
| | - Michel Delforge
- e Department of Hematology University Hospitals Leuven , Belgium
| | | | - Leo Rasche
- g Department of Internal Medicine II , University Hospital Wuerzburg , Wuerzburg , Germany
| | - Ajay K Nooka
- h Winship Cancer Institute, Emory University , Atlanta , GA , USA
| | - Agnieszka Druzd-Sitek
- i Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology , Warsaw , Poland
| | - Jan Walewski
- i Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology , Warsaw , Poland
| | - Julio Davila
- j Hospital Universitario De Salamanca , Salamanca , Spain
| | - Jo Caers
- k Centre Hospitalier Universitaire De Liege , Liege , Belgium
| | - Vladimir Maisnar
- l Department of Medicine - Haematology , Hradec Kralove , Czech Republic
| | - Morie Gertz
- m Division of Hematology , Mayo Clinic , Rochester , MN , USA
| | - Massimo Gentile
- n Hematology Unit, Department of Onco-Hematology , A.O. of Cosenza , Cosenza , Italy
| | - Dorotea Fantl
- o Hospital Italiano De Buenos Aires , Buenos Aires , Argentina
| | - Giuseppe Mele
- p Haematology, Ospedale A. Perrino , Brindisi , Italy
| | - David H Vesole
- q John Theurer Cancer Center at Hackensack University Medical Center , Hackensack , NJ , USA
| | - Andrew J Yee
- r Massachusetts General Hospital Cancer Center , Harvard Medical School , Boston , MA , USA
| | - Chaim Shustik
- s Royal Victoria Hospital, McGill University , Montreal , Canada
| | | | - Sonja Zweegman
- u VU University Medical Center , Amsterdam , the Netherlands
| | | | | | - Jorge J Castillo
- w Dana-Farber Cancer Institute, Harvard Medical School , Boston , MA , USA
| |
Collapse
|
7
|
Cutaneous Nodules in Multiple Myeloma. ACTAS DERMO-SIFILIOGRAFICAS 2015. [DOI: 10.1016/j.adengl.2015.06.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
8
|
Gómez-Armayones S, Climent F, Servitje O. Cutaneous Nodules in Multiple Myeloma. Cutaneous plasmacytoma associated with multiple myeloma. ACTAS DERMO-SIFILIOGRAFICAS 2015; 106:581-2. [PMID: 25935193 DOI: 10.1016/j.ad.2014.12.021] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2014] [Revised: 11/19/2014] [Accepted: 12/15/2014] [Indexed: 11/24/2022] Open
Affiliation(s)
- S Gómez-Armayones
- Servicio de Dermatología, Hospital Universitari de Bellvitge, Barcelona, España.
| | - F Climent
- Servicio de Anatomía Patológica, Hospital Universitari de Bellvitge, Barcelona, España
| | - O Servitje
- Servicio de Dermatología, Hospital Universitari de Bellvitge, Barcelona, España
| |
Collapse
|
9
|
Ormaechea-Pérez N, Vildosola-Esturo S, Aseginolatza-Zabaleta B, Lobo-Morán C, Jaka-Moreno A, Del Alcazar-Viladomiu E, Tuneu-Valls A. Violaceous nodules on the leg of a patient with multiple myeloma. Int J Dermatol 2013; 53:e296-8. [PMID: 24261997 DOI: 10.1111/ijd.12137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
10
|
Radiation therapy for secondary cutaneous plasmacytomas. Case Rep Hematol 2013; 2013:739230. [PMID: 24260722 PMCID: PMC3821948 DOI: 10.1155/2013/739230] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2013] [Accepted: 09/19/2013] [Indexed: 12/14/2022] Open
Abstract
We are reporting a case of a 75-year-old man with multiply recurrent IgA-lambda multiple myeloma status post multiple rounds of chemotherapy, autologous stem cell transplantation, and palliative radiation therapy for diffuse bone lesions. Approximately 15 years after original diagnosis, he developed secondary cutaneous plasmacytomas of the right arm, right chest wall, and right upper back over the course of several months. He underwent palliative involved field 3D conformal photon or en face electron therapy concurrently with various chemotherapy regimens and achieved good to complete response with palliation of pain at the irradiated sites. He died of complications related to his disease approximately 7 months after developing skin lesions. The case presented is unique for dermal involvement of myeloma treated with palliative involved field radiation.
Collapse
|
11
|
|
12
|
Sweet-Like Lesions Induced by Bortezomib: A Review of the Literature and a Report of 2 Cases. ACTAS DERMO-SIFILIOGRAFICAS 2012. [DOI: 10.1016/j.adengl.2012.03.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
13
|
Sweet-like lesions induced by bortezomib: a review of the literature and a report of 2 cases. ACTAS DERMO-SIFILIOGRAFICAS 2012; 103:829-31. [PMID: 22652505 DOI: 10.1016/j.ad.2012.03.002] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2011] [Revised: 03/01/2012] [Accepted: 03/02/2012] [Indexed: 11/24/2022] Open
|
14
|
Pink Nodule on the Forearm. Am J Dermatopathol 2012. [DOI: 10.1097/dad.0b013e318239bcb1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
15
|
MESSEGUER F, LLOMBART B, SANMARTÍN O, AGUSTI-MEJIAS A, TRAVES V, GUILLÉN C. Cutaneous involvement in multiple myeloma: Report of two cases. J Dermatol 2012; 39:806-8. [DOI: 10.1111/j.1346-8138.2012.01547.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
16
|
Cutaneous involvement in multiple myeloma mimicking acral-lentiginous melanoma. J Am Acad Dermatol 2010; 62:1076-8. [PMID: 20466190 DOI: 10.1016/j.jaad.2009.07.012] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2009] [Revised: 06/28/2009] [Accepted: 07/09/2009] [Indexed: 11/20/2022]
|